Ro Khanna bought Adient PLC (NYSE: ADNT)
Ro Khanna (D-CA), a U.S. Representative, has disclosed 1 trade in Adient PLC (ADNT) since 2018, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Ro Khanna bought $1,001 - $15,000 of Adient PLC (NYSE: ADNT) on October 7, 2018. Since that trade, ADNT is down -35.26% against the S&P 500 up +189.00%, an outperformance of -224.26%.
Data updated
Ro Khanna's ADNT trades vs the price
ADNT is down -35.26% since Ro Khanna bought on October 7, 2018, versus +189.00% for the S&P 500.
Performance since this trade
All Ro Khanna ADNT trades
Ro Khanna & ADNT trading FAQ
Is it legal for Ro Khanna to trade Adient PLC (ADNT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Adient PLC (ADNT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ro Khanna buy ADNT?
Ro Khanna disclosed a purchase of $1,001 - $15,000 of Adient PLC (ADNT) on October 7, 2018, according to public STOCK Act filings.
How has ADNT performed since Ro Khanna's trade?
Since Ro Khanna bought ADNT on October 7, 2018, the stock is down -35.26%, versus +189.00% for the S&P 500 over the same period, an outperformance of -224.26%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ADNT trades?
Quantellect tracks every disclosed congressional trade in Adient PLC (ADNT) on the Adient PLC congressional trading page, which aggregates filings across all members of Congress.
Ro Khanna's ADNT tradesAll congressional filings for Adient PLCRo Khanna's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.